Martin Edelman, MD

Professor, Chair, Department of Hematology/Oncology, G. Morris Dorrance Jr. Chair in Medical Oncology, Associate Cancer Center Director for Clinical Research Integration, Chair, Department of Medical Oncology, Lewis Katz School of Medicine at Temple University

Calculated based on number of publications stored in Pure and citations from Scopus
Calculated based on number of publications stored in Pure and citations from Scopus
Calculated based on number of publications stored in Pure and citations from Scopus
1975 …2024

Research activity per year

Personal profile

Research interests

RESEARCH INTERESTS

My professional career over the past 30 years has focused on interdisciplinary and multimodality treatment of lung cancer with the goal of translating laboratory observations into practical clinical trials. This includes the development of new agents and strategies for combining chemotherapy with radiation as well as determining potential markers for susceptibility or resistance to new drugs. I have also had a considerable interest in evaluating patient outcomes and the development of studies that extend the benefits of current approaches to underserved or compromised patient populations with thoracic malignancies. On a national level, I am the co-chair for the Lung Committee of the NRG, a cadre member of the Alliance Respiratory Committee.     Over the course of my career I have been the national PI for five NCI supported national trials in three different cooperative groups and co-chaired several others. I am currently co-chair of SWOG 1900 (Lung Master Protocol in Squamous Cell Carcinoma).   The five studies that I have chaired were initially developed by me and piloted at my primary academic institution.  I am a member of the Thoracic Malignancies Steering Committees for the NCI.  I have evaluated a number of novel biomarkers to evaluate disease burden, response to therapy and patient selection including CYFRA, VEGF, gp88, EGFR, beta tubulin III, etc. I have investigated novel approaches to modulating the tumor microenvironment as a strategy for improving immunotherapy, including inhibition of myeloid derived tumor cells and the COX-2 pathway.  In addition, I have also been involved in prevention efforts as a member of the Endpoint Verification Committee for the National Lung Screening Trial.  In addition, I have collaborated with health care economists, clinical psychologists and social scientists to evaluate clinical outcomes and address health care disparities, clinical trial participation and follow-up strategies.

CLINICAL INTERESTS

I am a thoracic medical oncologist. In my clinic I see patients with lung cancer (small cell and non-small cell), mesothelioma, thymic malignancies (thymoma, thymic carcinoma) and pulmonary carcinoid. I am an active researcher in novel therapeutics and strategies for the treatment of these diseases.

TEACHING AND EDUCATIONAL INTERESTS

As Department Chair, I supervise our overall educational programs in oncology, with a particular focus on our fellowship program as well as development of new faculty. 

Education/Academic qualification

Hematology/Oncology Fellowship, Naval Hospital, San Diego, CA

Sep 1987Aug 1990

Residency in Internal Medicine, Naval Hospital, San Diego, CA

Aug 1984Aug 1986

Internship in Internal Medicine, Naval Hospital, San Diego, CA

Jul 1982Jun 1983

Doctor of Medicine, The Albany Medical College, of Union University

1978May 1982

External positions

Member, Executive Committee, American Radium Society

2023 → …

ASCO In-Training Exam Task Force, American Society of Clinical Oncology

2023 → …

Member (ad hoc) , R21/R33/R01 Clinical Oncology

2021 → …

ASCO-SEP Item Writing Task Force, American Society of Clinical Oncology

2019 → …

Chair, Scientific Advisory Board, Lung Cancer Foundation of America

2018 → …

Scientific Advisory Board, Lung Cancer Foundation of America

2017 → …

Eastern Cooperative Oncology Group

2017 → …

Member, NCCN Small Cell Lung Cancer Panel, National Comprehensive Cancer Network

2017 → …

Thoracic malignancies steering committee

2014 → …

Co-Chair (Medical Oncology), NRG Lung Committee

2010 → …

Fingerprint

Dive into the research topics where Martin Edelman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or